Annovis Bio (ANVS) Change in Accured Expenses (2019 - 2026)
Annovis Bio (ANVS) reported Change in Accured Expenses of -$4.48 million for Q2 2026, compared with $696,636 a year earlier.
Powered by 
Analysis
Annovis Bio (ANVS) Change in Accured Expenses (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Annovis Bio's Change in Accured Expenses came in at $1.2 million, up 2.8% year-over-year; for FY2025, it was -$530,154.
- By year, Change in Accured Expenses came in at -$1.41 million in FY2024, -$751,012 in FY2023, $2.92 million in FY2022 (+401.6%) and $581,916 in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Change in Accured Expenses in data going back to Q1 2019.
- Per Business Quant data, the three quarters before Q2 2026 came in at $6.47 million (Q1 2026), -$576,912 (Q4 2025) and -$209,042 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Annovis Bio | 49.85 Mn | 49.85 Mn | - | -4.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.48 Mn |
| Mar 31, 2026 | 6.47 Mn |
| Dec 31, 2025 | -576,912.00 |
| Sep 30, 2025 | -209,042.00 |
| Jun 30, 2025 | 696,636.00 |
| Mar 31, 2025 | -440,836.00 |
| Dec 31, 2024 | 283,051.00 |
| Sep 30, 2024 | 629,280.00 |
| Jun 30, 2024 | -100,501.00 |
| Mar 31, 2024 | -2.22 Mn |
| Dec 31, 2023 | 1.35 Mn |
| Sep 30, 2023 | 737,527.00 |
| Jun 30, 2023 | -357,378.00 |
| Mar 31, 2023 | -2.48 Mn |
| Dec 31, 2022 | 3.06 Mn |
| Sep 30, 2022 | 283,286.00 |
| Jun 30, 2022 | -70,581.00 |
| Mar 31, 2022 | -350,315.00 |
| Dec 31, 2021 | -12,419.00 |
| Sep 30, 2021 | 62,068.00 |
API Access
Annovis Bio Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ANVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "ANVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ANVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();